These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10588324

  • 1. Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies.
    Martino R, Subirá M, Sureda A, Sierra J.
    J Antimicrob Chemother; 1999 Oct; 44(4):569-72. PubMed ID: 10588324
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM, Lumbreras C, González-Vidal D, Grupo de Farmacovigilancia de Abelcet.
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
    Linden P, Williams P, Chan KM.
    Clin Transplant; 2000 Aug; 14(4 Pt 1):329-39. PubMed ID: 10945204
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM, Seibel NL, Walsh TJ.
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR.
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [Abstract] [Full Text] [Related]

  • 9. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
    Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ.
    Clin Infect Dis; 1998 Jun; 26(6):1383-96. PubMed ID: 9636868
    [Abstract] [Full Text] [Related]

  • 10. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 11. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH, Dodds Ashley E, Benjamin DK, Duane Davis R, Palmer SM, Perfect JR.
    Transplantation; 2004 Jan 27; 77(2):232-7. PubMed ID: 14742987
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients.
    Herbrecht R, Auvrignon A, Andrès E, Guillemain R, Suc A, Eyer D, Pailler C, Letscher-Bru V, Leverger G, Schaison G.
    Eur J Clin Microbiol Infect Dis; 2001 Feb 27; 20(2):77-82. PubMed ID: 11305476
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS.
    Clin Infect Dis; 1996 Feb 27; 22(2):315-21. PubMed ID: 8838189
    [Abstract] [Full Text] [Related]

  • 17. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R, Reed MD, Chu A, Gotz V, Morris JA, Weinberg J, Dominguez EA.
    Clin Ther; 2004 Oct 27; 26(10):1652-62. PubMed ID: 15598482
    [Abstract] [Full Text] [Related]

  • 18. Renal effects of amphotericin B lipid complex.
    Luke RG, Boyle JA.
    Am J Kidney Dis; 1998 May 27; 31(5):780-5. PubMed ID: 9590187
    [Abstract] [Full Text] [Related]

  • 19. Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia.
    Fleming RV, Kantarjian HM, Husni R, Rolston K, Lim J, Raad I, Pierce S, Cortes J, Estey E.
    Leuk Lymphoma; 2001 Feb 27; 40(5-6):511-20. PubMed ID: 11426524
    [Abstract] [Full Text] [Related]

  • 20. Low-dose amphotericin B lipid complex for the treatment of persistent fever of unknown origin in patients with hematologic malignancies and prolonged neutropenia.
    Martino R, Subirá M, Domingo-Albós A, Sureda A, Brunet S, Sierra J.
    Chemotherapy; 1999 Feb 27; 45(3):205-12. PubMed ID: 10224343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.